Your browser doesn't support javascript.
loading
Next-generation sequencing profiling of miRNAs in individuals with 22q11.2 deletion syndrome revealed altered expression of miR-185-5p.
Dantas, Anelisa Gollo; Nunes, Beatriz Carvalho; Nunes, Natália; Galante, Pedro; Asprino, Paula Fontes; Ota, Vanessa Kiyomi; Melaragno, Maria Isabel.
Afiliação
  • Dantas AG; Genetics Division, Department of Morphology and Genetics, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Nunes BC; Genetics Division, Department of Morphology and Genetics, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Nunes N; Genetics Division, Department of Morphology and Genetics, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Galante P; Department of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria.
  • Asprino PF; Molecular Oncology Center, Hospital Sírio-Libanês, São Paulo, SP, Brazil.
  • Ota VK; Molecular Oncology Center, Hospital Sírio-Libanês, São Paulo, SP, Brazil.
  • Melaragno MI; Genetics Division, Department of Morphology and Genetics, Universidade Federal de São Paulo, São Paulo, Brazil.
Hum Genomics ; 18(1): 64, 2024 Jun 13.
Article em En | MEDLINE | ID: mdl-38872198
ABSTRACT

BACKGROUND:

The 22q11.2 deletion syndrome (22q11.2DS) is a microdeletion syndrome with highly variable phenotypic manifestations, even though most patients present the typical 3 Mb microdeletion, usually affecting the same ~ 106 genes. One of the genes affected by this deletion is DGCR8, which plays a crucial role in miRNA biogenesis. Therefore, the haploinsufficiency of DGCR8 due to this microdeletion can alter the modulation of the expression of several miRNAs involved in a range of biological processes.

RESULTS:

In this study, we used next-generation sequencing to evaluate the miRNAs profiles in the peripheral blood of 12 individuals with typical 22q11DS compared to 12 healthy matched controls. We used the DESeq2 package for differential gene expression analysis and the DIANA-miTED dataset to verify the expression of differentially expressed miRNAs in other tissues. We used miRWalk to predict the target genes of differentially expressed miRNAs. Here, we described two differentially expressed miRNAs in patients compared to controls hsa-miR-1304-3p, located outside the 22q11.2 region, upregulated in patients, and hsa-miR-185-5p, located in the 22q11.2 region, which showed downregulation. Expression of miR-185-5p is observed in tissues frequently affected in patients with 22q11DS, and previous studies have reported its downregulation in individuals with 22q11DS. hsa-miR-1304-3p has low expression in blood and, thus, needs more validation, though using a sensitive technology allowed us to identify differences in expression between patients and controls.

CONCLUSIONS:

Thus, lower expression of miR-185-5p can be related to the 22q11.2 deletion and DGCR8 haploinsufficiency, leading to phenotypic consequences in 22q11.2DS patients, while higher expression of hsa-miR-1304-3p might be related to individual genomic variances due to the heterogeneous background of the Brazilian population.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Perfilação da Expressão Gênica / MicroRNAs / Síndrome de DiGeorge / Sequenciamento de Nucleotídeos em Larga Escala Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Hum Genomics Assunto da revista: GENETICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Perfilação da Expressão Gênica / MicroRNAs / Síndrome de DiGeorge / Sequenciamento de Nucleotídeos em Larga Escala Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Revista: Hum Genomics Assunto da revista: GENETICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil